Home-based Psychoeducation for Older Adults With Frailty: A Feasibility Trial

Effects of A Home-based Psychoeducation Programme on Subjective Well-being for Older Adults With Frailty in the Community: A Feasibility Trial

This study aims to test the feasibility and acceptability of home-based psychoeducation in older adults with frailty in the community. The main questions it aims to answer are

1. Are the proposed eligibility criteria for participants and the study process in recruiting and retaining the participants appropriate?
2. Is home-based psychoeducation feasible and acceptable for older adults with frailty in the community?

Participants will receive 12 weekly online group-based sessions at their homes. The content for the experimental group and control group is different:

• Intervention group: psychoeducation
• Control group: physical health education

Participants will receive two home visits for data collection. An individual interview will be conducted with participants in the experimental group to explore their experiences.

Study Overview

• Status: Completed
• Conditions: Frailty; Well-Being, Psychological
• Intervention / Treatment: Other: Attention control; Other: Psychoeducation

• Study Type: Interventional
• Enrollment (Actual): 24
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Hong Kong
  • New Territories
    • Shatin, New Territories, Hong Kong
      • The Nethersole School of Nursing, The Chinese University of Hong Kong

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

(1) aged 65 years or over; (2) meeting frailty criteria by FRAIL scale (score 3 or above) ; (3) mentally competent screened by The Abbreviated Mental Test (AMT≥6) ; (4) able to speak and understand Cantonese; (5) living at home; (6) having experience using a smartphone (e.g.: sending messages, watching videos)

Exclusion Criteria:

(1) have a visual or hearing problem or a language barrier that may affect their communication or understanding; (2) being unfit for home-based exercise, as defined by having one point or above at either the 25-item Home Falls and Accidents self-reported screening tool (HOME-FAST), which is a comprehensive tool for identify home hazards for fall (3) are currently practising exercise for at least 150 minutes per week in previous four weeks; (4) are receiving active psychiatric or antidepressant treatment or joining other physical exercises or rehabilitation programmes

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Experimental group; Participants will receive 60-minute weekly online group-based psychoeducation sessions for 12 weeks.	Other: Psychoeducation; The content of psychoeducation is based on "Five Ways of Well-being" which covers "Be active", "Connect", "Take Notice", "Keep learning" and "Giving" . The participants will be engaged in psychoeducation through group discussion, individualised goal setting and reflective exercises.
Active Comparator: Control group; Participants will receive 60-minute weekly online group-based physical health sessions for 12 weeks.	Other: Attention control; The content of the sessions mainly focuses on physical health information, such as healthy eating, physical exercise, prevention of falls, and pain management.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Participation rate, self-reported intervention adherence, and attrition rate.	The feasibility of the study will be measured in terms of participation rate, self-reported intervention adherence, and attrition rate.	12 weeks post-allocation
Acceptability	A 5-item satisfaction survey will be conducted by the end of the intervention for participants to rate the intervention in terms of appropriates of the session content, length of each session, overall intervention duration and delivery mode, from 1 (very dissatisfied) to 5 (very satisfied).	12 weeks post-allocation

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Frailty level	FRAIL scale	12 weeks post-allocation
Physical functioning	The Senior Fitness Test: It covers four dimensions, including muscle endurance, balance, flexibility, and tolerance measured by 30-sec arm-curl test, 30-sec chair-stand test, back-scratch test, chair sit-and-reach test, 8-foot up-and-go test, two-min step test.	12 weeks post-allocation
Activities of daily living	Katz Index of Independence in Activities of Daily Living	12 weeks post-allocation
Instrumental activities of daily living	Lawton Instrumental Activities of Daily Living Scale	12 weeks post-allocation
Subjective well-being	The Chinese 5-item World Health Organization Well-Being Index	12 weeks post-allocation
Depressive symptoms	4-item Geriatric Depression scale	12 weeks post-allocation
Social support	10-item Duke Social Support Index	12 weeks post-allocation
Quality of life	EuroQol 5-Dimension 5-Level	12 weeks post-allocation

Collaborators and Investigators

• Sponsor: TAO An

Study record dates

Study Major Dates

• Study Start (Actual): November 24, 2023
• Primary Completion (Actual): April 9, 2024
• Study Completion (Actual): April 9, 2024

Study Registration Dates

• First Submitted: May 10, 2024
• First Submitted That Met QC Criteria: May 10, 2024
• First Posted (Actual): May 16, 2024

Study Record Updates

• Last Update Posted (Actual): May 16, 2024
• Last Update Submitted That Met QC Criteria: May 10, 2024
• Last Verified: May 1, 2024

More Information

Terms related to this study

• Keywords: frailty; psychoeducation; Subjective well-being
• Additional Relevant MeSH Terms: Pathologic Processes; Frailty
• Other Study ID Numbers: 2023.585.p

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No